JNJ Relative Valuation
JNJ's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, JNJ is overvalued; if below, it's undervalued.
Historical Valuation
Johnson & Johnson (JNJ) is now in the Undervalued zone, suggesting that its current forward PE ratio of 14.35 is considered Undervalued compared with the five-year average of 16.31. The fair price of Johnson & Johnson (JNJ) is between 191.85 to 213.05 according to relative valuation methord. Compared to the current price of 152.94 USD , Johnson & Johnson is Undervalued By 20.28%.
Relative Value
Fair Zone
191.85-213.05
Current Price：152.94
20.28%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
4.66
P/B
Median3y
5.52
Median5y
5.84
5.59
FCF Yield
Median3y
4.28
Median5y
4.47
Competitors Valuation Multiple
The average P/S ratio for JNJ's competitors is 4.07, providing a benchmark for relative valuation. Johnson & Johnson Corp (JNJ) exhibits a P/S ratio of 3.94, which is -3.17% above the industry average. Given its robust revenue growth of 2.39%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Johnson & Johnson (JNJ) currently overvalued or undervalued?
What is Johnson & Johnson (JNJ) fair value?
How does JNJ's valuation metrics compare to the industry average?
What is the current P/B ratio for Johnson & Johnson (JNJ) as of May 24 2025?
What is the current FCF Yield for Johnson & Johnson (JNJ) as of May 24 2025?
What is the current Forward P/E ratio for Johnson & Johnson (JNJ) as of May 24 2025?